Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an acute respiratory disease pandemic, termed coronavirus disease 2019 (COVID-19), that has resulted in considerable mortality and morbidity in the United States since early 2020.1 Several vaccines, including the use of messenger RNA (mRNA) vaccines, have proven to be effective against the multiple variant strains of COVID-19,2-5 and therefore, widespread vaccination of the public remains imperative. For patients with a history of allergic reaction to a previous COVID-19 vaccine, a graded administration protocol represents an option, with limited studies showing the safety or efficacy of this approach.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
